Pardes Biosciences Alpha and Beta Analysis
| PRDSDelisted Stock | USD 2.14 0.01 0.47% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Pardes Biosciences. It also helps investors analyze the systematic and unsystematic risks associated with investing in Pardes Biosciences over a specified time horizon. Remember, high Pardes Biosciences' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Pardes Biosciences' market risk premium analysis include:
Beta (0.15) | Alpha 0.4 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Pardes |
Pardes Biosciences Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Pardes Biosciences market risk premium is the additional return an investor will receive from holding Pardes Biosciences long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Pardes Biosciences. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Pardes Biosciences' performance over market.| α | 0.40 | β | -0.15 |
Pardes Biosciences Fundamentals Vs Peers
Comparing Pardes Biosciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Pardes Biosciences' direct or indirect competition across all of the common fundamentals between Pardes Biosciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as Pardes Biosciences or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Pardes Biosciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing Pardes Biosciences by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Pardes Biosciences to competition |
| Fundamentals | Pardes Biosciences | Peer Average |
| Return On Equity | -0.4 | -0.31 |
| Return On Asset | -0.26 | -0.14 |
| Current Valuation | (22.1 M) | 16.62 B |
| Shares Outstanding | 62.01 M | 571.82 M |
| Shares Owned By Insiders | 13.47 % | 10.09 % |
| Shares Owned By Institutions | 72.05 % | 39.21 % |
| Number Of Shares Shorted | 874.35 K | 4.71 M |
Pardes Biosciences Opportunities
Pardes Biosciences Return and Market Media
The Stock received some media coverage during the period. Price Growth (%) |
| Timeline |
1 | Why Acumen Pharmaceuticals Shares Are Trading Higher By Over 60 Here Are Other Stocks Moving In Mondays Mid-Day Session | 07/17/2023 |
2 | SHAREHOLDER ACTION ALERT The Schall Law Firm Announces it is Investigating Claims Against Pardes Biosciences, Inc. and Encourages Investors with Losses In Exces... | 07/19/2023 |
3 | INVESTIGATION ACTION ALERT The Schall Law Firm Announces it is Investigating Claims Against Pardes Biosciences, Inc. and Encourages Investors with Losses to Con... | 07/24/2023 |
About Pardes Biosciences Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Pardes or other delisted stocks. Alpha measures the amount that position in Pardes Biosciences has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Pardes Biosciences Upcoming Company Events
As portrayed in its financial statements, the presentation of Pardes Biosciences' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Pardes Biosciences' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Pardes Biosciences' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Pardes Biosciences. Please utilize our Beneish M Score to check the likelihood of Pardes Biosciences' management manipulating its earnings.
| 6th of November 2023 Upcoming Quarterly Report | View | |
| 12th of March 2024 Next Financial Report | View | |
| 30th of September 2023 Next Fiscal Quarter End | View | |
| 12th of March 2024 Next Fiscal Year End | View | |
| 30th of June 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Pardes Biosciences
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Consideration for investing in Pardes Stock
If you are still planning to invest in Pardes Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pardes Biosciences' history and understand the potential risks before investing.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |